CMAB Biopharma
Exclusively focused on delivering fully integrated CDMO services for biologics
Founded 2017
Suzhou, China
38 employees
Series B
Total: $72.00M
Biopharma, Biotechnology +1
Suzhou, China
38 employees
Series B
Total: $72.00M
Biopharma, Biotechnology +1
General Information
Company Name
CMAB Biopharma
Founded Year
2017
Location
Suzhou, China
Suzhou, China
Employees
38
Industries
Biopharma, Biotechnology, Manufacturing
Funding Stage
Series B
Social
BounceWatch is an independent company data service, not affiliated with CMAB Biopharma. To contact CMAB Biopharma, visit cmabbio.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does CMAB Biopharma compare?
A PDF of CMAB Biopharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting CMAB Biopharma soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is CMAB Biopharma on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
China Market
Biopharma
About CMAB Biopharma
Business keywords: CDMO, Biologics, Biopharmaceuticals, Monoclonal Antibody, Biosimilars, cGMP, Contract Development and Manufacturing Organization, Process Development, Manufacturing Services, Preclinical Drug Development, Clinical Drug Development, DNA Sequences, GMP Standards, BioBAY Park
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | $34.00M | 5 |
|
02 Apr 2018 |
| Series A | $38.00M | 3 |
|
02 Jan 2018 |
CMAB Biopharma Alternatives & Competitors
View All Alternatives
CMAB Biopharma vs
Canton Biologics
China
Reliable, efficient, and innovative, global biologics CDMSO for Biotech.
Series C
31 employees
Biotechnology, Manufacturing
CMAB Biopharma vs
JOINN Biologics US Inc.
United States
Your premier CDMO for biologics drug development and manufacturing, from early development, to IND,...
Series B
73 employees
Biopharma, Biotechnology
CMAB Biopharma vs
Innovent Biologics
53Biologics
FAQ About CMAB Biopharma
Exclusively focused on delivering fully integrated CDMO services for biologics
CMAB Biopharma was founded in 2017.
CMAB Biopharma is headquartered in Suzhou, China.
CMAB Biopharma operates in Biopharma, Biotechnology and Manufacturing. Its work centres on CDMO, Biologics, Biopharmaceuticals and Monoclonal Antibody.
CMAB Biopharma has approximately 38 employees.
CMAB Biopharma has completed 2 funding rounds, raising a total of $72.00M. The latest funding stage is Series B.
Top alternatives and competitors to CMAB Biopharma include Canton Biologics, JOINN Biologics US Inc., mAbxience, Innovent Biologics, Grand River Aseptic Manufacturing. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CMAB Biopharma and Canton Biologics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for CMAB Biopharma, https://bouncewatch.com/company/cmab-biopharma, updated 29 October 2024. When citing, please name BounceWatch and link this page.
